|Bid||40.60 x 800|
|Ask||40.61 x 4000|
|Day's Range||40.15 - 40.77|
|52 Week Range||23.39 - 40.77|
|Beta (3Y Monthly)||1.46|
|PE Ratio (TTM)||24.03|
|Forward Dividend & Yield||0.28 (0.79%)|
|1y Target Est||N/A|
Entegris (ENTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The companies have inked their definitive merger agreement, and regulatory filings show that several more Versum executives will be eligible to receive hefty bonuses after the deal is consummated.
Merger arbitrage spreads are an important tool investors can use to leverage the wisdom of crowds in their portfolios. There is a lot of useful information contained in just a few deal-related numbers. In the case of Anadarko, it looks like the market expects a higher bid.
Stocks with market capitalization between $2B and $10B, such as Entegris, Inc. (NASDAQ:ENTG) with a size of US$5.3b, do not attract as much attention from the investing community as do the small-caps and large-caps. However, histor...
The business combination received unanimous approval from the boards of the German pharmaceutical company and Versum, Merck said in a Friday press release. Versum is a supplier of process chemicals, gases and semiconductor manufacturing equipment.
Germany's Merck KGaA sealed a $6.5 billion (4.9 billion pounds) takeover deal with Versum Materials after overturning a deal it had agreed with rival bidder Entegris. A bet on a recovery in electronic materials markets for semiconductor makers, the transaction will boost the share of profit that diversified Merck derives from high-tech chemicals to 27 percent from 19 percent previously. Merck, also maker of pharmaceuticals and biotech production gear, this week won the backing of Versum's board for its $53-per-share offer, lifted from $48 previously, having been spurned for weeks.
Germany's Merck KGaA sealed a $6.5 billion takeover deal with Versum Materials after overturning a deal it had agreed with rival bidder Entegris. A bet on a recovery in electronic materials markets for semiconductor makers, the transaction will boost the share of profit that diversified Merck derives from high-tech chemicals to 27 percent from 19 percent previously. Merck, also maker of pharmaceuticals and biotech production gear, this week won the backing of Versum's board for its $53-per-share offer, lifted from $48 previously, having been spurned for weeks.
Germany's Merck KGaA said it signed a takeover agreement with target Versum Materials for a price of $53 per share after Versum walked away from a prior merger agreement with rival Entegris . Merck is targeting 75 million euros ($85 million) in run-rate synergies by the third full year after closing of the deal, which it expects in the second half of 2019, it said in a statement on Friday. Including about $700 million in assumed Versum debt and based on about 109 million shares, Merck's bid translates into a overall price tag of close to $6.5 billion.
After last-minute whirlwind trans-Atlantic negotiations, Tempe's Versum Materials Inc. has said it wants to pull out of a deal to merge with a U.S. company in order to be acquired by a much larger German corporation.
Entegris Inc NASDAQ/NGS:ENTGView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate and declining Bearish sentimentShort interest | PositiveShort interest is moderate for ENTG with between 5 and 10% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on March 13. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding ENTG are favorable, with net inflows of $2.30 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Technology sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Versum Materials, Inc . (NYSE: VSM ) announced Monday that it received a revised proposal from Merck KGaA to acquire Versum for $53 per share, up from Merck's prior $48-per-share proposal on Feb. 27. ...
Merck KGaA won the backing of Versum's board for a sweetened $6.5 billion takeover proposal, overturning an agreed merger with rival Entegris as it bets on a recovery in electronic materials markets. "This proposal constitutes a 'Superior Proposal' as defined in Versum's previously announced merger agreement with Entegris, Inc.," Versum said in a statement on Monday. On a per share basis, Germany's Merck offered $53, up from $48 previously, after reviewing business data and following meetings between Merck Chief Executive Stefan Oschmann and Versum Chairman Seifi Ghasemi, filings showed.
Versum, which had rejected Merck’s previous overtures, on Monday said it had agreed a $53 per share offer from the German healthcare and life sciences group that was superior to the all-stock deal it had struck with US rival Entegris in January. Merck will also assume Versum’s roughly $570m of net debt as part of the transaction. Merck had previously offered to pay $48 a share for Versum, before launching its hostile fight for the US chipmaker supplier.
Though Versum has said its board rejects a hostile takeover bid by Merck KGaA, company officials are continuing negotiations with the German suitor.
"Merck’s proposal could reasonably be expected to result in a superior proposal," Versum, a maker of chemicals for the semiconductor industry, cited its board as saying in a statement on Friday. The board "has authorized Versum's management and its advisers to engage in further discussions with, and provide non-public information to, Merck," the statement added.
FRANKFURT (Reuters) - Merck KGaA on Friday welcomed Versum Materials to the negotiation table after the takeover target said it was willing to hold talks over Merck's unsolicited offer. "We welcome ...
Versum Materials Inc on Friday urged its shareholders to reject a hostile bid from Merck KGaA , but said it would engage with the German pharma group to determine if the offer is superior to its agreed merger with rival Entegris. Merck KGaA had on Tuesday launched a $5.9 billion all-cash takeover offer for Versum, the former speciality chemicals division of industrial gases group Air Products, to boost its presence in the semiconductor materials market and sideline a rival bidder. Versum has been opposed to Merck's bid since it was first proposed last month, saying it was committed to an all-share merger with U.S. rival Entegris agreed in January.
To recap, Versum agreed to combine with rival Entegris Inc. in January. The market cheered, pushing Versum’s shares up 31 percent to $41, for a market value of $4.5 billion. Merck, capitalized at $48 billion, said a month later it wanted to buy Versum for $48 a share in cash, or $5.2 billion.
Versum announced in January it planned to merge with Entegris Inc. in a deal that would move the company’s headquarters out of Tempe into Entegris’ offices in Massachusetts.
German pharma group Merck KGaA launched a hostile $5.9 billion (£4.5 billion) all-cash takeover offer for Versum Materials on Tuesday to boost its presence in the semiconductor materials market and sideline a rival bidder. Versum, the former speciality chemicals division of industrial gases group Air Products, has been opposed to Merck's unsolicited cash offer since it was first proposed last month, saying it was committed to an all-share merger with U.S. rival Entegris agreed in January. Merck kept its offer price unchanged at $48 per share on Tuesday.
Merck KGaA is trying to break up Versum’s planned merger with Entegris. It’s a bold step, but it isn't clear if Merck KGaA will be successful. Strangely enough, the $48 tender price is still below where Versum stock trades today.
Versum Materials and Massachusetts-based Entegris have set April 26 as the date for stockholder meetings to vote on the companies' $9 billion proposed merger.